NO20013462L - Serinproteaseinhibitorer - Google Patents
SerinproteaseinhibitorerInfo
- Publication number
- NO20013462L NO20013462L NO20013462A NO20013462A NO20013462L NO 20013462 L NO20013462 L NO 20013462L NO 20013462 A NO20013462 A NO 20013462A NO 20013462 A NO20013462 A NO 20013462A NO 20013462 L NO20013462 L NO 20013462L
- Authority
- NO
- Norway
- Prior art keywords
- serine protease
- protease inhibitors
- compounds
- factor
- kallikrein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/18—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11577299P | 1999-01-13 | 1999-01-13 | |
| US15202999P | 1999-09-01 | 1999-09-01 | |
| PCT/US2000/000673 WO2000041531A2 (en) | 1999-01-13 | 2000-01-11 | Serine protease inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20013462D0 NO20013462D0 (no) | 2001-07-12 |
| NO20013462L true NO20013462L (no) | 2001-09-12 |
Family
ID=26813550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013462A NO20013462L (no) | 1999-01-13 | 2001-07-12 | Serinproteaseinhibitorer |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US6472393B1 (es) |
| EP (1) | EP1144373B1 (es) |
| JP (1) | JP2002534449A (es) |
| KR (1) | KR100838418B1 (es) |
| CN (1) | CN100488947C (es) |
| AT (1) | ATE307111T1 (es) |
| AU (1) | AU771776B2 (es) |
| BR (1) | BR0008755A (es) |
| CA (1) | CA2356934A1 (es) |
| CZ (1) | CZ20012508A3 (es) |
| DE (1) | DE60023266T2 (es) |
| ES (1) | ES2251363T3 (es) |
| HU (1) | HUP0105077A3 (es) |
| IL (2) | IL144032A0 (es) |
| MX (1) | MXPA01007038A (es) |
| NO (1) | NO20013462L (es) |
| NZ (1) | NZ512736A (es) |
| PL (1) | PL350042A1 (es) |
| WO (1) | WO2000041531A2 (es) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE307111T1 (de) * | 1999-01-13 | 2005-11-15 | Genentech Inc | Serinprotease-inhibitoren |
| WO2001023349A1 (fr) * | 1999-09-30 | 2001-04-05 | Mitsubishi Chemical Corporation | Derives d'acylsulfonamide |
| AU1339302A (en) | 2000-10-20 | 2002-05-06 | Biocryst Pharm Inc | Biaryl compounds as serine protease inhibitors |
| US7001887B2 (en) | 2001-02-02 | 2006-02-21 | Chugai Seiyaku Kabushiki Kaisha | Peptide derivatives |
| DE10130374A1 (de) * | 2001-06-23 | 2003-01-02 | Boehringer Ingelheim Pharma | Substituierte N-Acyl-anilinderivate, deren Herstellung und deren Verwendung als Arzneimittel |
| ATE399175T1 (de) * | 2002-03-11 | 2008-07-15 | Curacyte Ag | Hemmstoffe der urokinase, ihre herstellung und verwendung |
| GB0207637D0 (en) * | 2002-04-02 | 2002-05-15 | Karobio Ab | Novel compound |
| AU2003231865A1 (en) * | 2002-05-31 | 2003-12-19 | Genzyme Corporation | Alpha acyloxyacetamides for kallikrein and urokinase inhibition |
| DE10301300B4 (de) | 2003-01-15 | 2009-07-16 | Curacyte Chemistry Gmbh | Verwendung von acylierten 4-Amidino- und 4-Guanidinobenzylaminen zur Inhibierung von Plasmakallikrein |
| WO2004072102A2 (en) * | 2003-02-11 | 2004-08-26 | Bristol-Myers Squibb Company | Benzene acetamide compounds useful as serine protease inhibitors |
| US7122559B2 (en) * | 2003-02-11 | 2006-10-17 | Bristol-Myers Squibb Company | Phenylglycine derivatives useful as serine protease inhibitors |
| EP1628954A2 (en) * | 2003-05-20 | 2006-03-01 | Genentech, Inc. | Acylsulfamide inhibitors of factor viia |
| US7273886B2 (en) * | 2003-05-20 | 2007-09-25 | Genentech, Inc. | Benzofuran inhibitors of factor VIIa |
| DE10342108A1 (de) * | 2003-09-11 | 2005-04-14 | Curacyte Chemistry Gmbh | Basisch-substituierte Benzylaminanaloga als Inhibitoren des Gerinnungsfaktors Xa, ihre Herstellung und Verwendung |
| US7622585B2 (en) * | 2005-01-10 | 2009-11-24 | Bristol-Myers Squibb Company | Phenylglycinamide derivatives useful as anticoagulants |
| US7514410B2 (en) | 2005-03-29 | 2009-04-07 | Biocryst Pharmaceuticals, Inc. | Hepatitis C therapies |
| US8101636B2 (en) * | 2005-06-03 | 2012-01-24 | The University Of North Carolina At Chapel Hill | Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| US7964619B2 (en) * | 2005-06-03 | 2011-06-21 | The University Of North Carolina At Chapel Hill | Teraryl components as antiparasitic agents |
| DE602006011752D1 (de) * | 2005-06-24 | 2010-03-04 | Bristol Myers Squibb Co | Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate |
| PT2000465E (pt) * | 2006-03-24 | 2011-02-10 | Eisai R&D Man Co Ltd | Derivado de triazolona |
| US7776832B2 (en) | 2006-04-21 | 2010-08-17 | Gem Pharmaceuticals, Llc | Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines |
| DE102006050672A1 (de) | 2006-10-24 | 2008-04-30 | Curacyte Discovery Gmbh | Hemmstoffe des Plasmins und des Plasmakallikreins |
| TW200831080A (en) * | 2006-12-15 | 2008-08-01 | Irm Llc | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| ES2390188T3 (es) | 2007-01-12 | 2012-11-07 | Biocryst Pharmaceuticals, Inc. | Análogos de nucleósidos antivirales |
| CA2874595A1 (en) | 2007-04-13 | 2009-02-19 | Southern Research Institute | Use of terfenadine for treating breast and ovarian tumors |
| EP2178849A1 (en) * | 2007-07-31 | 2010-04-28 | Mallinckrodt Inc. | Integrated photoactive agents and uses thereof |
| WO2009038157A1 (ja) | 2007-09-21 | 2009-03-26 | Eisai R & D Management Co., Ltd. | ２，３－ジヒドロ－イミノイソインドール誘導体 |
| TW200942243A (en) | 2008-03-05 | 2009-10-16 | Biocryst Pharm Inc | Antiviral therapeutic agents |
| WO2010036407A2 (en) | 2008-05-15 | 2010-04-01 | Biocryst Pharmaceuticals, Inc. | Antiviral nucleoside analogs |
| JP5667094B2 (ja) | 2009-03-10 | 2015-02-12 | エムイーディー ディスカバリー エスエー | 好中球減少症の処置におけるセリンプロテアーゼ阻害剤の使用 |
| TW201206905A (en) | 2010-05-20 | 2012-02-16 | Eisai R & Amp D Man Co Ltd | Prodrug of triazolone compound |
| ES2483802T3 (es) | 2010-07-07 | 2014-08-07 | The Medicines Company (Leipzig) Gmbh | Inhibidores de serina proteasa |
| EP2844660B1 (en) | 2012-05-02 | 2017-11-01 | Southern Research Institute | Triazolopyridazine compounds, use as inhibitors of the kinase lrrk2, and methods for preparation thereof |
| CA2939219C (en) | 2014-02-11 | 2023-02-28 | Mitokinin Llc | Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease |
| US10023579B2 (en) | 2015-12-16 | 2018-07-17 | Southern Research Institute | Pyrrolopyrimidine compounds, use as inhibitors of the kinase LRRK2, and methods for preparation thereof |
| WO2018094227A1 (en) | 2016-11-17 | 2018-05-24 | The University Of North Carolina At Chapel Hill | Alkyl pyrrolopyrimidine analogs and methods of making and using same |
| US10450263B2 (en) | 2017-02-10 | 2019-10-22 | Southern Research Institute | Benzo annulenes as antiviral agents |
| US11160826B1 (en) | 2017-03-03 | 2021-11-02 | United States Government As Represented By The Department Of Veterans Affairs | Cholesterol lowering drugs for the treatment of hepatic encephalopathy |
| WO2018237145A1 (en) | 2017-06-21 | 2018-12-27 | Mitokinin, Inc. | COMPOSITIONS AND METHODS USING THEM FOR THE TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE |
| CA3080193A1 (en) | 2017-10-26 | 2019-05-02 | Southern Research Institute | Dipeptide analogs as tgf-beta inhibitors |
| WO2019089693A1 (en) | 2017-10-31 | 2019-05-09 | Southern Research Institute | Substituted quinazoline sulfonamides as thioredoxin interacting protein (txnip) inhibitors |
| TW202010742A (zh) | 2018-04-06 | 2020-03-16 | 美商百歐克斯製藥公司 | 取代的苯并呋喃、苯并吡咯、苯并噻吩及結構相關的補體抑制劑 |
| CA3097003A1 (en) | 2018-04-19 | 2019-10-24 | Southern Research Institute | 4'-thio-nucleotide and -nucleoside prodrugs for the treatment of cancer |
| CN114502174A (zh) | 2019-06-14 | 2022-05-13 | 南方研究院 | 2,4,7取代的-7-脱氮-2′-脱氧-2′-氟阿拉伯糖基核苷和核苷酸前药及其用途 |
| JP2023520480A (ja) | 2020-04-02 | 2023-05-17 | サウザーン リサーチ インスチチュート | アルファウイルスに対する強力な抗ウイルス剤としての新規２－ピリミドン類似体 |
| US11753374B2 (en) | 2020-11-18 | 2023-09-12 | Southern Reserach Institute | Compounds for the treatment of acute and chronic kidney disease |
| EP4247375A1 (en) | 2020-11-18 | 2023-09-27 | Southern Research Institute | Compounds for the treatment of acute and chronic kidney disease |
| WO2023122212A2 (en) | 2021-12-21 | 2023-06-29 | Southern Research Institute | Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of sars virus |
| WO2023147352A1 (en) | 2022-01-27 | 2023-08-03 | Trilink Biotechnologies, Llc | Trinucleotide cap analogs and methods of use thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA928276B (en) | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
| DE4342154A1 (de) | 1993-12-10 | 1995-06-14 | Behringwerke Ag | Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien |
| US5869501A (en) | 1994-12-02 | 1999-02-09 | Yamanouchi Pharmaceutical Co. Ltd | Amidinonaphthyl derivative or salt thereof |
| ES2208737T3 (es) * | 1995-03-10 | 2004-06-16 | Berlex Laboratories, Inc. | Derivados de benzamidina, su preparacion y su utilizacion como anticoagulantes. |
| WO1997049404A1 (en) * | 1996-06-25 | 1997-12-31 | Eli Lilly And Company | Anticoagulant agents |
| US6020357A (en) * | 1996-12-23 | 2000-02-01 | Dupont Pharmaceuticals Company | Nitrogen containing heteroaromatics as factor Xa inhibitors |
| TW542822B (en) * | 1997-01-17 | 2003-07-21 | Ajinomoto Kk | Benzamidine derivatives |
| WO1998046628A1 (en) * | 1997-04-14 | 1998-10-22 | Cor Therapeutics, Inc. | SELECTIVE FACTOR Xa INHIBITORS |
| JP2002513412A (ja) * | 1997-04-14 | 2002-05-08 | シーオーアール セラピューティクス インコーポレイテッド | 選択的Ｘａ因子阻害剤 |
| EP0977772A1 (en) * | 1997-04-14 | 2000-02-09 | Cor Therapeutics, Inc. | SELECTIVE FACTOR Xa INHIBITORS |
| AU6896398A (en) * | 1997-04-14 | 1998-11-11 | Cor Therapeutics, Inc. | Selective factor xa inhibitors |
| DE19718181A1 (de) | 1997-04-30 | 1998-11-05 | Boehringer Ingelheim Pharma | Disubstituierte bicyclische Heterocyclen, ihre Herstellung und ihre Verwendung als Arzneimittel |
| US5998424A (en) * | 1997-06-19 | 1999-12-07 | Dupont Pharmaceuticals Company | Inhibitors of factor Xa with a neutral P1 specificity group |
| EP0987274A1 (en) * | 1998-09-15 | 2000-03-22 | Hoechst Marion Roussel Deutschland GmbH | Factor VIIa Inhibitors |
| ATE307111T1 (de) * | 1999-01-13 | 2005-11-15 | Genentech Inc | Serinprotease-inhibitoren |
-
2000
- 2000-01-11 AT AT00911572T patent/ATE307111T1/de not_active IP Right Cessation
- 2000-01-11 JP JP2000593153A patent/JP2002534449A/ja active Pending
- 2000-01-11 CN CNB008044228A patent/CN100488947C/zh not_active Expired - Fee Related
- 2000-01-11 AU AU33451/00A patent/AU771776B2/en not_active Ceased
- 2000-01-11 HU HU0105077A patent/HUP0105077A3/hu not_active Application Discontinuation
- 2000-01-11 KR KR1020017008804A patent/KR100838418B1/ko not_active IP Right Cessation
- 2000-01-11 EP EP00911572A patent/EP1144373B1/en not_active Expired - Lifetime
- 2000-01-11 CZ CZ20012508A patent/CZ20012508A3/cs unknown
- 2000-01-11 DE DE60023266T patent/DE60023266T2/de not_active Expired - Lifetime
- 2000-01-11 WO PCT/US2000/000673 patent/WO2000041531A2/en active IP Right Grant
- 2000-01-11 IL IL14403200A patent/IL144032A0/xx active IP Right Grant
- 2000-01-11 PL PL00350042A patent/PL350042A1/xx not_active Application Discontinuation
- 2000-01-11 ES ES00911572T patent/ES2251363T3/es not_active Expired - Lifetime
- 2000-01-11 NZ NZ512736A patent/NZ512736A/en not_active IP Right Cessation
- 2000-01-11 US US09/509,104 patent/US6472393B1/en not_active Expired - Fee Related
- 2000-01-11 BR BRPI0008755-6A patent/BR0008755A/pt not_active Application Discontinuation
- 2000-01-11 CA CA002356934A patent/CA2356934A1/en not_active Abandoned
- 2000-01-11 MX MXPA01007038A patent/MXPA01007038A/es active IP Right Grant
-
2001
- 2001-06-27 IL IL144032A patent/IL144032A/en not_active IP Right Cessation
- 2001-07-12 NO NO20013462A patent/NO20013462L/no not_active Application Discontinuation
-
2002
- 2002-08-19 US US10/224,114 patent/US6919369B2/en not_active Expired - Fee Related
-
2005
- 2005-03-24 US US11/088,511 patent/US20050186198A1/en not_active Abandoned
-
2006
- 2006-09-29 US US11/537,482 patent/US20070037813A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE307111T1 (de) | 2005-11-15 |
| EP1144373A3 (en) | 2002-01-02 |
| NO20013462D0 (no) | 2001-07-12 |
| CA2356934A1 (en) | 2000-07-20 |
| BR0008755A (pt) | 2007-05-29 |
| CN1342139A (zh) | 2002-03-27 |
| ES2251363T3 (es) | 2006-05-01 |
| CZ20012508A3 (cs) | 2002-02-13 |
| EP1144373A2 (en) | 2001-10-17 |
| US20050186198A1 (en) | 2005-08-25 |
| AU771776B2 (en) | 2004-04-01 |
| IL144032A (en) | 2006-06-11 |
| PL350042A1 (en) | 2002-10-21 |
| US20030212071A1 (en) | 2003-11-13 |
| HUP0105077A2 (hu) | 2002-05-29 |
| HUP0105077A3 (en) | 2005-04-28 |
| MXPA01007038A (es) | 2002-07-30 |
| AU3345100A (en) | 2000-08-01 |
| CN100488947C (zh) | 2009-05-20 |
| JP2002534449A (ja) | 2002-10-15 |
| US20070037813A1 (en) | 2007-02-15 |
| NZ512736A (en) | 2003-11-28 |
| EP1144373B1 (en) | 2005-10-19 |
| US6919369B2 (en) | 2005-07-19 |
| DE60023266D1 (de) | 2005-11-24 |
| KR100838418B1 (ko) | 2008-06-13 |
| KR20010101852A (ko) | 2001-11-15 |
| IL144032A0 (en) | 2002-04-21 |
| WO2000041531A3 (en) | 2001-08-16 |
| DE60023266T2 (de) | 2006-07-13 |
| WO2000041531A2 (en) | 2000-07-20 |
| US6472393B1 (en) | 2002-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE307111T1 (de) | Serinprotease-inhibitoren | |
| PT1383731E (pt) | Compostos de biarilo como inibidores de serina-protease | |
| ATE268766T1 (de) | Stickstoff enthaltende heterobicyclen als factor xa inhibitoren | |
| DE60122750D1 (de) | Amidine-inhibitoren der serine-proteasen | |
| TR200103493T2 (tr) | Metaloproteaz önleyicileri | |
| NO20015462D0 (no) | Anvendelse av fthalazinderivater | |
| TW200637843A (en) | Phenylglycinamide derivatives useful as anticoagulants | |
| WO2004113278A3 (en) | Acylsulfamide inhibitors of factor viia | |
| TR200402535T4 (tr) | Serin proteaz inhibitörleri. | |
| TR199801569T2 (xx) | Serin proteaz inhibit�rleri. | |
| SE9602646D0 (sv) | Pharmaceutically-useful compounds | |
| ATE304532T1 (de) | Inhibitoren von serin proteasen | |
| NO20004698L (no) | Quinoksalinoner som serin protease inhibitorer sÕ som faktor XA og trombin | |
| GB0030303D0 (en) | Compounds | |
| EE200000322A (et) | Uued ühendid | |
| TR199801704T2 (xx) | Serin proteaz inhibit�rleri. | |
| DE60113252D1 (de) | Inhibitoren von serin proteasen | |
| EE200100315A (et) | Amidinoderivaadid ja nende kasutamine trombiini inhibiitoritena | |
| SE0001803D0 (sv) | New compounds i | |
| BR0017074A (pt) | Combinações de inibidor de ace-antagonista de vasopressina | |
| IS7162A (is) | Nýjar möndlusýruafleiður og notkun þeirra sem þrombínhemla | |
| ATE290878T1 (de) | Inhibierung von invasiver remodulierung | |
| WO2003051831A3 (en) | Protease inhibitors of the coagulation cascade isolated from dysidea sponges |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |